<SEC-DOCUMENT>0001513162-13-000278.txt : 20130415
<SEC-HEADER>0001513162-13-000278.hdr.sgml : 20130415
<ACCEPTANCE-DATETIME>20130412212931
ACCESSION NUMBER:		0001513162-13-000278
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20130408
ITEM INFORMATION:		Unregistered Sales of Equity Securities
FILED AS OF DATE:		20130415
DATE AS OF CHANGE:		20130412

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOMERICA INC
		CENTRAL INDEX KEY:			0000073290
		STANDARD INDUSTRIAL CLASSIFICATION:	DENTAL EQUIPMENT & SUPPLIES [3843]
		IRS NUMBER:				952645573
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-08765
		FILM NUMBER:		13759775

	BUSINESS ADDRESS:	
		STREET 1:		17571 VON KARMAN AVENUE
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614
		BUSINESS PHONE:		9496452111

	MAIL ADDRESS:	
		STREET 1:		17571 VON KARMAN AVENUE
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NMS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19871130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR MEDICAL SYSTEMS INC
		DATE OF NAME CHANGE:	19830216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR INSTRUMENTS INC
		DATE OF NAME CHANGE:	19720508
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>biomerica8k4813.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<head><title>SECURITIES AND EXCHANGE COMMISSION</title> </head> <body style="MARGIN-TOP:0px; FONT-FAMILY:Times New Roman; COLOR:#000000; FONT-SIZE:10pt"> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>SECURITIES AND EXCHANGE COMMISSION</p> <p style=MARGIN:0px><br></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>WASHINGTON, D.C.</p> <p style=MARGIN:0px><br></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>FORM 8-K</p> <p style=MARGIN:0px><br></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>CURRENT REPORT</p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px><br></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>Pursuant to Section 13 or 15(d) of the</p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>Securities Exchange Act of 1934</p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px><br></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center><u>_____ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;April 8, 2013__________</u></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>Date of Report (date of earliest event reported)</p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center><u>BIOMERICA, INC.</u></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>(Exact Name of Registrant as Specified in its Charter)</p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>&nbsp;</p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center> <table cellspacing=0> <tr> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px"> <p align=center><u>Delaware</u></p></td> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px" /> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </td> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px"> <p align=center><u>0-8765</u></p></td> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </td> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px" /> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px"> <p align=center><u>95-2645573</u></p></td></tr> <tr> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px"> <p align=center>(State or Other</p></td> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px" /> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px" /> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px"> <p align=center>(Commission</p></td> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px" /> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px" /> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px"> <p align=center>(IRS Employer</p></td></tr> <tr> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px"> <p align=center>Jurisdiction of</p></td> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px" /> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px" /> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px"> <p align=center>File Number)</p></td> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px" /> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px" /> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px"> <p align=center>Identification Number)</p></td></tr> <tr> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px"> <p align=center>Incorporation</p></td> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px" /> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px" /> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px"> <p align=center>&nbsp;</p></td> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px" /> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px" /> <td style="BORDER-BOTTOM:0px; BORDER-LEFT:0px; BORDER-TOP:0px; BORDER-RIGHT:0px" /></tr></table></p> <p style=MARGIN:0px><br>&nbsp;</p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>17571 Von Karman Ave.</p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center><u>Irvine, California 92614</u></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>(Address of Principal Executive Offices</p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>Including Zip Code)</p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center><u>949-645-2111</u></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>(Registrant&#146;s Telephone Number,</p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>Including Area Code)</p> <p style=MARGIN:0px align=center><br></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>______________</p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>(Former Name or Former Address if Changed</p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>Since Last Report)</p> <p style=MARGIN:0px align=center><br></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>Page 1 of 3 pages</p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>&nbsp;</p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>&nbsp;</p> <p style=MARGIN:0px align=center>&nbsp;</p> <hr size=1 noshade style="MARGIN-BOTTOM:9px; PADDING-TOP:9px"> <p style="PAGE-BREAK-BEFORE:always; MARGIN:0px; FONT-SIZE:12pt"><b><u>Item 3.02. Unregistered Sales of Equity Securities. </u></b></p> <p style=MARGIN:0px><br></p> <p style="MARGIN:0px; FONT-SIZE:12pt">On April 3, 2013, Biomerica, Inc. (the &#147;Company&#148;) entered into a Stock Purchase Agreement (the &#147;Stock Purchase Agreement&#148;) with an accredited investor named therein (the &#147;Investor&#148;). &nbsp;Pursuant to the terms of the Stock Purchase Agreement, the Company agreed to sell a total of 400,000 &nbsp;shares (the &#147;Shares&#148;) of its common stock, $0.08 par value per share (the &#147;Common Stock&#148;), at a price of $1.25 per share for aggregate gross proceeds of $500,000 (the &#147;Private Placement&#148;). The initial closing under the Stock Purchase Agreement occurred on April 8, 2013 for half the purchase price ($250,000). &nbsp;There can be no assurance that the remaining $250,000 purchase price will be purchased.</p> <p style=MARGIN:0px><br></p> <p style="MARGIN:0px; FONT-SIZE:12pt">Pursuant to the Stock Purchase Agreement, the Company and the Investor made representations and warranties regarding matters that are customarily included in financings of this nature. The obligations of the Company to sell and issue the Shares, and the obligations of the Investors to purchase the Shares, were subject to the fulfillment of specified conditions prior to the closing of the Private Placement, which have been satisfied as of the date of this Current Report on Form 8-K.</p> <p style=MARGIN:0px><br></p> <p style="MARGIN:0px; FONT-SIZE:12pt">The Company expects the Private Placement of the Shares to result in gross proceeds to the Company of approximately $250,000 before the deduction of expenses related to the Private Placement payable by the Company. The Shares were offered and are to be sold in the Private Placement to an accredited investor without registration under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), or state securities laws, in reliance on the exemptions provided by Section 4(2) of the Securities Act and Regulation D promulgated thereunder and in reliance on similar exemptions under applicable state laws. &nbsp;</p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px align=center><br>&nbsp;</p> <hr size=1 noshade style="MARGIN-BOTTOM:9px; PADDING-TOP:9px"> <p style="PAGE-BREAK-BEFORE:always; MARGIN:0px; PADDING-RIGHT:28px; FONT-SIZE:12pt" align=center><u>SIGNATURES</u></p> <p style=MARGIN:0px><br></p> <p style="MARGIN:0px; PADDING-RIGHT:28px; FONT-SIZE:12pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p> <p style=MARGIN:0px><br></p> <p style="MARGIN-TOP:0px; WIDTH:336px; MARGIN-BOTTOM:-2px; FLOAT:left; FONT-SIZE:12pt">Dated: &nbsp;April 12, 2013</p> <p style="TEXT-INDENT:-2px; MARGIN:0px; PADDING-RIGHT:28px; FONT-SIZE:12pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Biomerica, Inc.</p> <p style="MARGIN:0px; CLEAR:left"><br></p> <p style="TEXT-INDENT:336px; MARGIN:0px; PADDING-RIGHT:28px; FONT-SIZE:12pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By: <u>/s/ Zackary S. Irani</u></p> <p style="TEXT-INDENT:384px; MARGIN:0px; PADDING-RIGHT:28px; FONT-SIZE:12pt">Zackary S. Irani</p> <p style="TEXT-INDENT:384px; MARGIN:0px; PADDING-RIGHT:28px; FONT-SIZE:12pt">Chief Executive Officer</p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br><br></p></body>
<!-- EDGAR Validation Code: 3A2963F2 -->
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
